According to the company, BIOMEnd contains L-Lysine Butyrate, the l-lysine salt of butyric acid, which is superior in form and completely soluble in liquid solution.
The solutions will combine human milk oligosaccharides (HMOs) from dsm-firmenich and probiotics from Lallemand Health Solutions with the aim to make the composition of infant formula closer to breast milk.
Sirio Pharma is delivering immune supporting postbiotics in an approachable gummy format while Kerry is offering multiple benefits via its Plenibiotics postbiotic ingredient.